Construction of nursing-sensitive quality indicator system for cardiac rehabilitation of patients undergoing percutaneous coronary intervention based on structure-process-outcome m...

por Kang, Lei, Wang, Min-hui, Wu, Sheng-jia
Publicado 2023

Vitamin D and the Immune System from the Nephrologist's Viewpoint

por Lang, Cheng-Lin, Wang, Min-Hui, Chiang, Chih-Kang, Lu, Kuo-Cheng
Publicado 2014

Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon?

por Lang, Cheng-Lin, Wang, Min-Hui, Hung, Kuan-Yu, Chiang, Chih-Kang, Lu, Kuo-Cheng
Publicado 2013

Correlation of Interleukin-17-Producing Effector Memory T Cells and CD4(+)CD25(+)Foxp3 Regulatory T Cells with the Phosphate Levels in Chronic Hemodialysis Patients

por Lang, Cheng-Lin, Wang, Min-Hui, Hung, Kuan-Yu, Hsu, Sung-Hao, Chiang, Chih-Kang, Lu, Kuo-Cheng
Publicado 2014

Scale up of Transmembrane NADH Oxidation in Synthetic Giant Vesicles

por Wang, MinHui, Weber, André, Hartig, Roland, Zheng, Yiran, Krafft, Dorothee, Vidaković-Koch, Tanja, Zuschratter, Werner, Ivanov, Ivan, Sundmacher, Kai
Publicado 2021

Phase II study of acalabrutinib in ibrutinibintolerant patients with relapsed/refractory chronic lymphocytic leukemia

por Rogers, Kerry A., Thompson, Philip A., Allan, John N., Coleman, Morton, Sharman, Jeff P., Cheson, Bruce D., Jones, Daniel, Izumi, Raquel, Frigault, Melanie M., Quah, Cheng, Raman, Rakesh K., Patel, Priti, Wang, Min Hui, Kipps, Thomas J.
Publicado 2021

Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results

por Ghia, Paolo, Pluta, Andrzej, Wach, Małgorzata, Lysak, Daniel, Šimkovič, Martin, Kriachok, Iryna, Illés, Árpád, de la Serna, Javier, Dolan, Sean, Campbell, Philip, Musuraca, Gerardo, Jacob, Abraham, Avery, Eric J., Lee, Jae Hoon, Usenko, Ganna, Wang, Min Hui, Yu, Ting, Jurczak, Wojciech
Publicado 2022

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chro...

por Sharman, Jeff P., Egyed, Miklos, Jurczak, Wojciech, Skarbnik, Alan, Pagel, John M., Flinn, Ian W., Kamdar, Manali, Munir, Talha, Walewska, Renata, Corbett, Gillian, Fogliatto, Laura Maria, Herishanu, Yair, Banerji, Versha, Coutre, Steven, Follows, George, Walker, Patricia, Karlsson, Karin, Ghia, Paolo, Janssens, Ann, Cymbalista, Florence, Woyach, Jennifer A., Ferrant, Emmanuelle, Wierda, William G., Munugalavadla, Veerendra, Yu, Ting, Wang, Min Hui, Byrd, John C.
Publicado 2022